TransMedics Group WKN: A2PH5P ISIN: US89377M1099 Kürzel: TMDX Forum: Aktien Thema: Hauptdiskussion

Top zahlen, Ausblick angehoben. Schmeckt

https://finance.yahoo.com/news/transmedics-tmdx-q2-earnings-revenues-214512785.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAABCmTeUi1PfBK9fGI6U8ogG87y1tWw_xQR3CE_x6OlDFqkpuEhzZMbtbvsfPY_02zAvvOovtIfACFvDOO9ZakCrlnCWjJIK71uo1FtPqXwN2XDUNGjgv13D9Al5ATc9DB55_bbHWTigC9_C6MBJ9vKKATvfeKf7NUpa_l9CY-n-6

https://www.prnewswire.com/news-releases/transmedics-reports-second-quarter-2024-financial-results-302211506.html

Verkauft 75% meiner Position. Über 350% plus. Den Rest lasse ich laufen

Beste aktie

Kiss me where it smells funny!

https://www.prnewswire.com/news-releases/transmedics-reports-first-quarter-2024-financial-results-302132100.html

Geile Aktie, episches Wachstum. Stärker als SaaS/Cloud Player und ohne Wettbewerb! Bin schon fast 300% im Plus

https://seekingalpha.com/news/4071880-transmedics-group-gaap-eps-of-0_12-beats-0_16-revenue-of-81_2m-beats-12_7m • TransMedics Group press release (NASDAQ:TMDX): Q4 GAAP EPS of $0.12 beats by $0.16. • Revenue of $81.2M (+158.6% Y/Y) beats by $12.7M. • The increase was due primarily to the increase in utilization of the OCS through the National OCS Program ("NOP") as well as additional revenue generated by the addition of TransMedics logistics services. • TransMedics expects total revenue for full-year 2024 to be in the range of $360 million to $370 million, which represents 49% to 53% growth compared to the company's prior year revenue.

🍀

TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results https://www.prnewswire.com/news-releases/transmedics-reports-fourth-quarter-and-full-year-2023-financial-results-302071645.html

🧐

Multi Bagger in the making, nächstes Jahr FCF positiv und ab geht die Reise. Management ist Klasse, alles eingehaltenen was gesagt wurde bisher!

TransMedics Group GAAP EPS of -$0.78 misses by $0.59, revenue of $66.4M beats by $17.22M https://seekingalpha.com/news/4031358-transmedics-group-gaap-eps-of-0_78-misses-0_59-revenue-of-66_4m-beats-17_22m • TransMedics Group press release (NASDAQ:TMDX): Q3 GAAP EPS of -$0.78 misses by $0.59. • Revenue of $66.4M (+158.4% Y/Y) beats by $17.22M. ... • Closed acquisition of Summit Aviation, enabling the addition of aviation service to NOP offering, driving $2.1 million incremental transplant related revenue in the third quarter • TransMedics is updating its full year 2023 revenue guidance to be in the range of $222 million to $230 million, vs. consensus of $194.03M, which represents 138% to 146% growth compared to the company's prior year revenue. TransMedics' prior 2023 revenue guidance was $180 million to $190 million.

TransMedics Reports Third Quarter 2023 Financial Results https://www.prnewswire.com/news-releases/transmedics-reports-third-quarter-2023-financial-results-301979063.html

Herzlichen Glückwunsch! Perfektes Timing!